Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel as Adjunctive Therapy for Refractory Partial Seizures
NCT00699582Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2008
- Primary completion
- Dec 2010
- Modality
- Classical Binding Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of perampanel in focal seizures, sponsored by Eisai Co., Ltd.. Started May 2008; status: completed.
02
Drugs
perampanel
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00699582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699582.